Behavioral Sciences Training in Drug Abuse Research

自1984年成立以来，药物滥用行为科学培训研究方案(BST) 成为全国最大和最古老的NRSA项目之一，专门培训行为科学家 从事药物滥用研究和相关问题，特别是艾滋病毒/艾滋病研究。BST培养了218名博士后和 博士后实习生--其中近一半是少数族裔。此应用程序请求授权以 维持目前职位的数目--36年中每年7名博士后和9名博士后实习生 到40岁。BST位于纽约大学罗里·迈耶斯护理学院。它与 药物使用和艾滋病毒/丙型肝炎研究中心(CDUHR)，NIDA最大和最古老的专注于药物的P30中心 使用和传染病(也在迈尔斯)，以及国家开发和研究机构，Inc.， 一个独立的研究机构，专门从事药物滥用研究。首席调查员Dr。 Gregory Falkin管理BST项目已有34年；他与George De Leon博士密切合作， 项目联席主任兼科学顾问，负责培训和项目运作的方方面面。BST核心 教职员工由42名CDUHR附属调查人员组成，他们目前管理着近100笔赠款-约一半是 由NIDA资助-为学员提供广泛的顶尖专家指导的机会 NIDA的研究报告。BST的任务是培养行为科学家，特别是种族/民族科学家 少数族裔，从事药物滥用研究的职业。该计划旨在通过：(1)招聘和 任命有前途的行为科学家，其中至少三分之一是少数族裔；(2)提供先进的 药物滥用研究和理论、研究方法和实践以及责任人方面的培训 进行研究；及。(3)就受训人员的职业生涯、研究及 美国国立卫生研究院的拨款申请。BST计划的显著特点使其成为真正独特的T32， 是否(A)受训人员组成一个不同的群体--他们来自广泛的行为纪律和 族裔/种族背景；(B)核心教员包括42名药物滥用问题的主要专家，他们管理着数十名 NIDA资助的赠款；(C)不只是纽约大学，各大学都招收了预科博士；(D)受训者获得 包括课堂学习的高强度培训(他们每周一以小组形式在 举办各种BST研讨会和讲习班，并辅之以CDUHR培训)和实践 对自己设计的项目和NIDA研究的研究经验-他们可以灵活地选择 他们参与的项目--和博士后撰写赠款申请；以及(E)所有研究员都收到了可观的 来自多位导师的指导，包括计划总监、BST核心教员和其他教员(例如， 论文委员会成员)。BST的长期成功体现在其重大贡献上 通过研究和出版物而脱颖而出的研究员，这些研究和出版物的数量超过1500 他们作为独立资助的NIH调查人员取得了成功--他们已经获得了大约100笔NIH拨款。

Since its inception in 1984, the Behavioral Science Training in Drug Abuse Research program (BST) has become one of the nation's largest and oldest NRSA programs specializing in training behavioral scientists for careers in drug abuse research and related issues, especially HIV/AIDS. BST has trained 218 predoctoral and postdoctoral trainees—nearly half of them racial/ethnic minorities. This application requests authorization to maintain the current number of positions—7 postdoctoral and 9 predoctoral trainees—during each of years 36 to 40. BST is housed in the Rory Meyers College of Nursing at New York University. It collaborates with the Center for Drug Use and HIV/HCV Research (CDUHR), NIDA's largest and oldest P30 center focusing on drug use and infectious diseases (also housed at Myers), and National Development and Research Institutes, Inc., a freestanding research institute that specializes in drug abuse research. The Principal Investigator, Dr. Gregory Falkin has managed the BST program for 34 years; he works closely with Dr. George De Leon, the program's Co-Director and Scientific Advisor, in all aspects of training and program operations. The BST core faculty comprises 42 CDUHR affiliate investigators who currently manage nearly 100 grants—about half are funded by NIDA—providing ample opportunity for trainees to be mentored by leading experts on a wide range of NIDA research studies. The BST mission is to prepare behavioral scientists, especially racial/ethnic minorities, for careers in drug abuse research. The program aims to accomplish this by: (1) recruiting and appointing promising behavioral scientists, at least one third of whom are minorities; (2) providing advanced training in substance abuse research and theory, research methods and practices, and the responsible conduct of research; and (3) mentoring and advising trainees on their careers as well as their research and NIH grant submissions. Distinguishing features of the BST program that combined make it a truly unique T32, are that (a) trainees comprise a diverse group—they come from a wide range of behavioral disciplines and ethnic/racial backgrounds; (b) the core faculty includes 42 leading experts on drug abuse who manage dozens of NIDA-funded grants; (c) predocs are enrolled at various universities, not just NYU; (d) the trainees receive highly intensive training that involves classroom learning (they meet as a group all day every Monday in a variety of BST seminars and workshops, which are supplemented by CDUHR trainings) and hands-on research experience on projects of their own design and NIDA studies—they have the flexibility to choose the projects they work on—and postdocs write grant applications; and (e) all fellows receive considerable mentorship from multiple mentors, including the Program Directors, core BST faculty, and other faculty (e.g., thesis committee members). BST's long-standing success is evident in the significant contributions of its fellows who have distinguished themselves through research and publications, which number over 1,500, and their success as independently funded NIH investigators—they have obtained about 100 NIH grants.